Why the study?
Do angiotensin-converting enzyme inhibitors slow the progression of chronic renal disease in nondiabetic patients?
Population
Nondiabetic patients with chronic renal disease
Design
Review
Authors
Loading...
Insufficient evidence precludes ACE inhibitor use to slow nondiabetic renal progression; leaves open need for rigorous randomized trials.
Do angiotensin-converting enzyme inhibitors slow the progression of chronic renal disease in nondiabetic patients?
A critical review of the literature reveals insufficient evidence to conclude that ACE inhibitors slow the progression of nondiabetic chronic renal disease in humans.
Pieter M. ter Wee (1993) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: